Anna Vanoverschelde

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Prognostic Factors

Glycemic Control

Top Venues

BMJ open respiratory research

The pharmacogenomics journal

The Journal of antimicrobial chemotherapy

European respiratory review : an official journal of the European Respiratory Society

This page only lists publications with an associated author ORCID identifier.

Publications

Delphine Vauterin, Frauke Van Vaerenbergh, Maxim Grymonprez, Anna Vanoverschelde, Lies Lahousse
Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis. BMJ open respiratory research 11 (1) (2024)
Delphine Vauterin, Frauke Van Vaerenbergh, Anna Vanoverschelde, Jennifer Kathleen Quint, Katia M C Verhamme, Lies Lahousse
Methods to assess COPD medications adherence in healthcare databases: a systematic review. European respiratory review : an official journal of the European Respiratory Society 32 (169) (2023)
Anna Vanoverschelde, Paulien van der Wel, Barbara Putman, Lies Lahousse
Determinants of poor inhaler technique and poor therapy adherence in obstructive lung diseases: a cross-sectional study in community pharmacies. BMJ open respiratory research 8 (1) (2021)
Anna Vanoverschelde, Berthe C Oosterloo, Nelly F Ly, M Arfan Ikram, André Goedegebure, Bruno H Stricker, Lies Lahousse
Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss. The Journal of antimicrobial chemotherapy 76 (10) (2021)
Anna Vanoverschelde, Paulien van der Wel, Barbara Putman, Lies Lahousse
A pragmatic randomized controlled trial to improve inhaler technique using mHealth. Clinical and translational allergy 10 (1) (2020)
Ahmed Edris, Anna Vanoverschelde, Pranvera Bushaj, Filip Van Nieuwerburgh, Lies Lahousse
Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists. The pharmacogenomics journal 21 (1) (2020)